Innovative Biosensors raises $3.5m
This article was originally published in Clinica
College Park, Maryland-based Innovative Biosensors has raised $3.5m to be invested in commercialising its pathogen testing technology. The firm, which was established in 2003 with technology licensed from Massachusetts Institute of Technology, has already launched an E coli detection kit and plans to introduce more products for food testing and human clinical diagnostics. The company claims its technology provides rapid results without sacrificing sensitivity. The series A fundraising was led by Harbert Venture Partners. Clinica FILED 1 June 2005 COPYRIGHT T&F Informa UK Ltd 2005
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.